Journal of Pharma and Drug Innovation

Frequency : Bi-Annual (Two issues per year)
Editorial & Review Timeline
3 - 6 Days Initial Quality Review
30 Days Peer Evaluation Summary
45 - 60 Days Complete Editorial Processing Time

Aim and Scope

The Journal of Pharma and Drug Innovation (JPDI) publishes high-quality research in pharmaceutical sciences and drug development. The journal focuses on the discovery, development, and evaluation of therapeutic agents, as well as advancements in pharmaceutical technologies.

The journal welcomes original research articles, review articles, short communications, and case studies in the following areas:

  • Drug design, discovery, and development
  • Advanced and targeted drug delivery systems
  • Pharmacology and pharmacodynamics
  • Pharmaceutical formulation and quality assurance
  • Clinical pharmacology and therapeutic innovations
  • Natural product drug development and toxicological studies
  • Nanomedicine and biosimilar development
  • Pharmaceutical biotechnology and biopharmaceuticals
  • Regulatory science, pharmacovigilance, and GMP compliance
  • Rational drug use, healthcare policy, and patient safety


JPDI encourages interdisciplinary research integrating pharmacy, medicine, chemistry, and life sciences, with the aim of advancing knowledge in drug discovery and therapeutic innovation.